Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

Public

Shared by NobleBlocks on Aug 1, 2022 • 12:00 AM UTC

Authors:

Robin Kate Kelley

Lorenza Rimassa

Ann-Lii Cheng

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!